Summit Therapeutics Inc. (SMMT)
Nasdaq · Common stock · Pharmaceutical Preparations
As of Oct 21, 2:17 PM ET15 min delayedAbout 15 minutes behind the market. Every member plan is real time.
Follow SMMT in real time
Real-time quotes, Pro Charting, the scanner and the alert feed on SMMT and every other US listing.
Start 5 days freeTry Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.
SMMT at a glance
Key statistics
$12.84B
Market capitalization
- Previous close
- $16.09
- Open
- $16.29
- Day range
- $15.89 – $16.31
- Volume
- 3.52M
- Average volume (30 sessions)
- 6.77M
- Shares outstanding
- 797.75M
- Earnings per share
- $(1.07)
- Price / book
- 20.4
- Beta (1 year, vs SPY)
- 1.64
Where the price sits in its year
52-week range
23% of the range
- Below the 52-week high
- -45.1%
- Above the 52-week low
- +33.0%
Completed sessions through Oct 20, 2026
Technical snapshot
Above its 50-day average, below its 200-day
- 20-day average
- $16.37-1.7%
- 50-day average
- $15.74+2.2%
- 200-day average
- $16.28-1.2%
Between the conventional 30 and 70 bands.
+3.7%
1 week
-4.8%
1 month
+9.2%
3 months
-8.0%
Year to date
-23.3%
1 year
Price change over each window, from completed sessions. Past performance does not indicate future results.
Every plan: MACD, ATR, the 20- and 50-day ranges, five-year and all-history extremes and the full indicator set, live on Pro Charting.The member platform, in real time
What members do with SMMT
SMMT on Pro Charting
Every intraday interval in real time, the drawing kit and the full set of technical studies on SMMT.
See the plans →
Every planScreen names like SMMT
The real-time scanner: price, volume, technical, fundamental and chart-pattern filters across the whole US market.
See the plans →
Analysis Tools OnlySet a price line on SMMT
Put SMMT on your watchlist, draw the levels you care about, and My Dashboard tracks where it trades against them.
See the plans →
Stock Alerts + ToolsOpen alerts on SMMT
See whether there is an open premium alert on SMMT, with its entry, stop and exit, each one reviewed by an analyst before it is sent.
See the plans →
From the public news wire
SMMT headlines
- FDA Accepts Summit's Lung Cancer Drug Application, Review Underway
Benzinga · Jan 29, 2026
- What's Going On With Summit Therapeutics Stock On Monday?
Benzinga · Oct 20, 2025
- Summit Therapeutics' Lung Cancer Drug Under Dark Clouds As Keytruda Challenger Shows Regional Data Differences
Benzinga · Sep 8, 2025
- Why Is Summit Therapeutics Stock Trading Higher On Monday?
Benzinga · Apr 28, 2025
- What's Going On With Summit Therapeutics Stock On Friday?
Benzinga · Apr 25, 2025
SEC Form 4, most recent first
Insider filings
Anand Bhaskar
+100.0K
Chief Accounting Officer · Grant or award
· Oct 8, 2026
DUGGAN ROBERT W
+3.81M
Co-Chief Executive Officer, Director, 10% owner · Open-market purchase
$49.99M · Jun 12, 2026
Zanganeh Mahkam
+3.81M
Co-Chief Executive Officer, Director, 10% owner · Open-market purchase
$49.99M · Jun 12, 2026
DUGGAN ROBERT W
+100.0K
Co-Chief Executive Officer, Director, 10% owner · Open-market purchase
$1.46M · Jun 4, 2026
Zanganeh Mahkam
+100.0K
Co-Chief Executive Officer, Director, 10% owner · Open-market purchase
$1.46M · Jun 4, 2026
Soni Manmeet Singh
+25.0K
COO and CFO, Director · Open-market purchase
$361.50K · Jun 4, 2026
Soni Manmeet Singh
+25.0K
COO and CFO, Director · Open-market purchase
$360.75K · Jun 4, 2026
Anand Bhaskar
+30.0K
Chief Accounting Officer · Grant or award
· Jan 8, 2026
About Summit Therapeutics Inc.
Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.
- Exchange
- Nasdaq
- Security
- Common stock
- Industry
- Pharmaceutical Preparations
- Headquarters
- Miami, FL
- Employees
- 265
- Listed since
- Mar 5, 2015
- Website
- smmttx.com
Pick the desk that fits how you trade
Analysis Tools Only for the real-time scanner, Pro Charting and the research desk. Stock Alerts + Tools for the human-reviewed alert feed. Premium Membership for both, at one price.
Try Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.
Other plans from $39 a month. Pay by card, Apple Pay, Google Pay, Link, Cash App Pay or Amazon Pay through Stripe.